Rapport Therapeutics Appoints Chief Financial Officer
October 30, 2023 09:00 AM Eastern Daylight Time BOSTON & SAN DIEGO–(BUSINESS WIRE)–Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision neuromedicines, today announced the appointment of industry veteran Troy Ignelzi as Chief Financial Officer, effective November 1, 2023. “Rapport’s innovative scientific approach to precision neuromedicine, which creates tremendous opportunity to dramatically improve patient outcomes, is incredibly … Continue reading Rapport Therapeutics Appoints Chief Financial Officer